Skip header and navigation

Refine By

3 records – page 1 of 1.

Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis.

https://arctichealth.org/en/permalink/ahliterature168274
Source
J Med Microbiol. 2006 Aug;55(Pt 8):1043-51
Publication Type
Article
Date
Aug-2006
Author
Mia Antila
Qiushui He
Caroline de Jong
Ingrid Aarts
Harold Verbakel
Sylvia Bruisten
Suzanne Keller
Marjo Haanperä
Johanna Mäkinen
Erkki Eerola
Matti K Viljanen
Jussi Mertsola
Anneke van der Zee
Author Affiliation
Pertussis Reference Laboratory, National Public Health Institute, Kiinamyllynkatu 13, 20520 Turku, Finland. mia.antila@tyks.fi
Source
J Med Microbiol. 2006 Aug;55(Pt 8):1043-51
Date
Aug-2006
Language
English
Publication Type
Article
Keywords
Bacterial Proteins - genetics
Base Sequence
Bordetella - genetics - isolation & purification
DNA Transposable Elements - genetics
DNA, Bacterial - genetics
Finland - epidemiology
Humans
Molecular Sequence Data
Nasopharynx - microbiology
Netherlands - epidemiology
Polymerase Chain Reaction - methods
Rec A Recombinases - genetics
Sensitivity and specificity
Sequence Alignment
Whooping Cough - diagnosis - epidemiology
Abstract
Bordetella holmesii is a Gram-negative bacterium first identified in 1995. It can cause pertussis-like symptoms in humans. B. holmesii contains insertion sequences IS481 and IS1001, two frequently used targets in the PCR diagnosis of Bordetella pertussis and Bordetella parapertussis infections. To investigate the prevalence of B. holmesii in Finnish and Dutch patients with pertussis-like symptoms and whether B. holmesii has caused any false-positive results in diagnostic PCRs, B. holmesii-specific real-time PCRs were developed. The Finnish methods were conventional IS481 PCR and B. holmesii-specific real-time PCR (LightCycler, Roche) targeting the B. holmesii recA gene. The Dutch methods were IS481 and IS1001 PCRs with conventional or real-time formats and B. holmesii-specific real-time PCR targeting the homologue of IS1001. Of 11,319 nasopharyngeal swabs, 2804 were collected from Finnish patients from 2000 to 2003, and 8515 from Dutch patients from 1992 to 2003. B. holmesii DNA was not found in the samples analysed. The results suggest that B. holmesii is not among the causative agents of pertussis-like symptoms in Finnish and Dutch patients and thus does not in practice confound IS481 and IS1001 PCRs.
PubMed ID
16849724 View in PubMed
Less detail

Bordetella pertussis isolates, Finland.

https://arctichealth.org/en/permalink/ahliterature176145
Source
Emerg Infect Dis. 2005 Jan;11(1):183-4
Publication Type
Article
Date
Jan-2005
Author
Johanna Mäkinen
Jussi Mertsola
Frits R Mooi
Shirley Van Amersfoorth
Heikki Arvilommi
Matti K Viljanen
Quishui He
Source
Emerg Infect Dis. 2005 Jan;11(1):183-4
Date
Jan-2005
Language
English
Publication Type
Article
Keywords
Adult
Bordetella pertussis - classification - genetics - isolation & purification
Child
DNA Fingerprinting - methods
Disease Outbreaks
Electrophoresis, Gel, Pulsed-Field
Finland - epidemiology
Humans
Schools
Urban Population
Whooping Cough - epidemiology - microbiology - transmission
Notes
Cites: J Clin Microbiol. 2002 Jun;40(6):1994-200112037054
Cites: Lancet Infect Dis. 2002 Dec;2(12):744-5012467690
Cites: J Med Microbiol. 2003 Dec;52(Pt 12):1059-6314614063
Cites: JAMA. 2003 Dec 10;290(22):2968-7514665658
Cites: J Clin Microbiol. 1994 Feb;32(2):398-4028150949
Cites: J Infect Dis. 1994 Sep;170(3):705-88077734
Cites: Microbiology. 1996 Dec;142 ( Pt 12):3479-859004510
Cites: Pediatr Infect Dis J. 1999 Apr;18(4):366-7010223692
Cites: Infect Immun. 1999 Jun;67(6):3133-410338531
Cites: Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):174-8110795589
PubMed ID
15714669 View in PubMed
Less detail

Interferon-gamma-dependent Immunity in Bacillus Calmette-Guérin Vaccine Osteitis Survivors.

https://arctichealth.org/en/permalink/ahliterature281961
Source
Pediatr Infect Dis J. 2016 06;35(6):690-4
Publication Type
Article
Date
06-2016
Author
Laura Pöyhönen
Liisa Kröger
Heini Huhtala
Johanna Mäkinen
Jussi Mertsola
Ruben Martinez-Barricarte
Jean-Laurent Casanova
Jacinta Bustamante
Qiushui He
Matti Korppi
Source
Pediatr Infect Dis J. 2016 06;35(6):690-4
Date
06-2016
Language
English
Publication Type
Article
Keywords
Adult
BCG Vaccine - administration & dosage - adverse effects
Female
Finland
Humans
Immunologic Factors - genetics
Interferon-gamma - secretion
Interleukin-12 - secretion
Leukocytes, Mononuclear - immunology
Male
Middle Aged
Mycobacterium bovis - immunology
Osteitis - chemically induced - immunology
Survivors
Young Adult
Abstract
Inborn errors of interferon-gamma (IFN-?)-mediated immunity underlie disseminated disease caused by Mycobacterium bovis Bacillus Calmette-Guérin (BCG) live vaccines. We hypothesized that some patients with osteitis after BCG vaccination may have an impaired IFN-? immunity. Our aim was to investigate interleukin (IL)-12 and IFN-? ex vivo production stimulated with BCG and BCG + IFN-? or BCG + IL-12, respectively, in BCG osteitis survivors.
Fresh blood samples were collected from 132 former BCG osteitis Finnish patients now aged 21-49 years, and IL-12 and IFN-? were measured in cell cultures with and without stimulation with BCG and with BCG + IFN-? or BCG + IL-12, respectively. As a pilot study, known disease-causing genes controlling IFN-? immunity (IFNGR1, IFNGR2, STAT1, IL12B, IL12RB1, ISG15, IRF8, NEMO and CYBB) were investigated in 20 selected patients by whole exome sequencing.
By the limit of
Notes
Cites: Allergol Immunopathol (Madr). 2015 Sep-Oct;43(5):456-6025201764
Cites: Acta Paediatr. 2015 May;104(5):485-9025605403
Cites: Pediatr Infect Dis J. 1994 Feb;13(2):113-68190535
Cites: Arch Dis Child. 1984 Feb;59(2):157-616703766
Cites: Eur J Pediatr. 2007 Aug;166(8):835-4117120032
Cites: J Allergy Clin Immunol. 2008 Dec;122(6):1043-51; quiz 1052-319084105
Cites: J Immunol. 2010 Jul 1;185(1):15-2220562268
Cites: Genome Res. 2010 Sep;20(9):1297-30320644199
Cites: Nucleic Acids Res. 2010 Sep;38(16):e16420601685
Cites: Medicine (Baltimore). 2010 Nov;89(6):381-40221057261
Cites: Clin Genet. 2011 Jan;79(1):17-2220718793
Cites: PLoS Med. 2011 Mar;8(3):e100101221445325
Cites: Curr Opin Immunol. 2002 Aug;14(4):452-712088679
Cites: J Infect Dis. 1995 Aug;172(2):574-67622909
Cites: N Engl J Med. 1996 Dec 26;335(26):1956-618960475
Cites: Eur J Immunol. 2004 Nov;34(11):3276-8415384045
Cites: Lancet. 2004 Dec 11-17;364(9451):2113-2115589309
Cites: PLoS One. 2011;6(4):e1852421533230
Cites: Hum Mutat. 2012 Sep;33(9):1377-8722573496
Cites: Acta Paediatr. 2013 Nov;102(11):1095-923865867
Cites: Pediatr Int. 2013 Oct;55(5):641-324134752
Cites: BMC Genomics. 2014;15:25624694260
Cites: J Interferon Cytokine Res. 2014 May;34(5):307-1724359575
Cites: Semin Immunol. 2014 Dec;26(6):454-7025453225
Cites: Immunol Rev. 2015 Mar;264(1):103-2025703555
Cites: Annu Rev Immunol. 2002;20:581-62011861613
PubMed ID
26954602 View in PubMed
Less detail